Search for Clinical Trial Results

Sponsored By

Carcinoid Syndrome - 25 Studies Found

Status Study
Completed Study Name: Bevacizumab and PEG-Interferon Alfa-2b in Treating Patients With Metastatic or Unresectable Carcinoid Tumors
Condition:
  • Metastatic Gastrointestinal Carcinoid Tumor
  • Recurrent Gastrointestinal Carcinoid Tumor

    • Date: 2003-03-06
    Interventions:
    • Biological: PEG-interferon alfa-2b

Completed Study Name: Gastrointestinal Motility in Patients With Neuroendocrine Tumors
Condition: Neuroendocrine Tumor
Date: 2008-11-11
Interventions: Device: Magnetic Tracking System (MTS) and radio-opaque markers MTS: A small magnetic pill (6x15mm) is s
Completed Study Name: Capecitabine and Streptozocin With or Without Cisplatin in Treating Patients With Unresectable or Metastatic Neuroendocrine Tumors
Condition:
  • Gastrointestinal Carcinoid Tumor
  • Islet Cell Tumor

Date: 2008-01-25
Interventions:
  • Drug: capecitabine
  • Drug: cisplatin
Completed Study Name: AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine Tumors
Condition:
  • Gastrointestinal Carcinoid Tumor
  • Islet Cell Tumor
  • Neoplast
    Date: 2007-01-25
    Interventions:
    • Drug: AMG 706 AMG 706 was admi
Completed Study Name: Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine Tumors
Condition:
  • Gastrointestinal Carcinoid Tumor
  • Islet Cell Tumor
  • Lung Can
    Date: 2005-09-26
    Interventions:
    • Biological: bevacizumab 5mg/kg
<<< Previous